Naveris

Naveris Develops Highly Sensitive Cancer Blood Tests for Early Diagnosis in General Asymptomatic Populations, Real-Time Monitoring of Treatment Responses, and Detection of Cancer Recurrence in Patients in Remission. Our tests utilize disruptive proprietary technology to capture and analyze cancer-related DNA in plasma, with improved sensitivity compared to existing ctDNA tests.